The table below shows OCULAR THERAPEUTIX, INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
-
-
-
Cost of revenue
$6.57M
$5.63M
$5.28M
$4.54M
$4.41M
$2.08M
Gross profit
-
-
-
-
-
-
R&D
$197.10M
$127.64M
$61.05M
$53.46M
$50.08M
$28.69M
SG&A
$64.38M
OCUL annual revenue (10-K history)
OCULAR THERAPEUTIX, INC reported annual revenue of $51.95M for fiscal year 2025. That is down 18.5% from $63.72M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.89M (FY 2016) to $51.95M. Figures come from the company's audited annual reports as filed with the SEC.